| Aging effects on cerebral blood and cerebrospinal fluid flows S Stoquart-ElSankari, O Balédent, C Gondry-Jouet, M Makki, O Godefroy, ... Journal of Cerebral Blood Flow & Metabolism 27 (9), 1563-1572, 2007 | 310 | 2007 |
| Immune-mediated neurological syndromes in SARS-CoV-2-infected patients A Guilmot, S Maldonado Slootjes, A Sellimi, M Bronchain, B Hanseeuw, ... Journal of neurology 268, 751-757, 2021 | 208 | 2021 |
| A phase-contrast MRI study of physiologic cerebral venous flow S Stoquart-ElSankari, P Lehmann, A Villette, M Czosnyka, ME Meyer, ... Journal of Cerebral Blood Flow & Metabolism 29 (6), 1208-1215, 2009 | 181 | 2009 |
| Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis? M D'haeseleer, S Hostenbach, I Peeters, SE Sankari, G Nagels, ... Journal of Cerebral Blood Flow & Metabolism 35 (9), 1406-1410, 2015 | 150 | 2015 |
| Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer's disease: a differential diagnosis from idiopathic normal pressure hydrocephalus S El Sankari, C Gondry-Jouet, A Fichten, O Godefroy, JM Serot, ... Fluids and Barriers of the CNS 8, 1-11, 2011 | 108 | 2011 |
| A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI P Lehmann, P Monet, G de Marco, G Saliou, M Perrin, ... European neurology 64 (1), 21-26, 2010 | 100 | 2010 |
| Phase-contrast MR imaging support for the diagnosis of aqueductal stenosis S Stoquart-El Sankari, P Lehmann, C Gondry-Jouet, A Fichten, ... American Journal of Neuroradiology 30 (1), 209-214, 2009 | 93 | 2009 |
| Intracranial lipomas: clinical appearances on neuroimaging and clinical significance G Jabot, S Stoquart-Elsankari, G Saliou, P Toussaint, H Deramond, ... Journal of neurology 256, 851-855, 2009 | 88 | 2009 |
| Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls S ElSankari, O Balédent, V Van Pesch, C Sindic, Q De Broqueville, ... Journal of Cerebral Blood Flow & Metabolism 33 (9), 1314-1321, 2013 | 82 | 2013 |
| Value of phase contrast magnetic resonance imaging for investigation of cerebral hydrodynamics O Baledent, C Gondry-Jouet, S Stoquart-Elsankari, R Bouzerar, D Le Gars, ... Journal of neuroradiology 33 (5), 292-303, 2006 | 62 | 2006 |
| Motor and cognitive slowing in multiple sclerosis: An attentional deficit? S Stoquart-ElSankari, C Bottin, M Roussel-Pieronne, O Godefroy Clinical neurology and neurosurgery 112 (3), 226-232, 2010 | 59 | 2010 |
| Timed Up-and-Go and 2-Minute Walk Test in patients with multiple sclerosis with mild disability: reliability, responsiveness and link with perceived fatigue. M Valet, T Lejeune, M Devis, V Van Pesch, S El Sankari, G Stoquart European journal of physical and rehabilitation medicine 55 (4), 450-455, 2018 | 56 | 2018 |
| B cell depletion therapy does not resolve chronic active multiple sclerosis lesions P Maggi, CV Bulcke, E Pedrini, C Bugli, A Sellimi, M Wynen, A Stölting, ... EBioMedicine 94, 2023 | 48 | 2023 |
| Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management B Decallonne, E Bartholomé, V Delvaux, M D’haeseleer, S El Sankari, ... Acta Neurologica Belgica 118, 153-159, 2018 | 41 | 2018 |
| Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? P Lehmann, G Saliou, G de Marco, P Monet, SE Souraya, A Bruniau, ... European journal of radiology 81 (3), 522-527, 2012 | 40 | 2012 |
| Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients F London, S El Sankari, V Van Pesch Clinical Neurophysiology 128 (4), 561-569, 2017 | 39 | 2017 |
| Effects of fampridine in people with multiple sclerosis: a systematic review and meta-analysis M Valet, M Quoilin, T Lejeune, G Stoquart, V Van Pesch, S El Sankari, ... CNS drugs 33, 1087-1099, 2019 | 36 | 2019 |
| Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis C Druart, S El Sankari, V Van Pesch Patient related outcome measures, 1-10, 2017 | 30 | 2017 |
| Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus X Finné Lenoir, C Sindic, V Van Pesch, S El Sankari, M de Tourtchaninoff, ... Neurocritical care 18, 89-92, 2013 | 29 | 2013 |
| MRI and diffusion-weighted imaging followup of a stroke-like event in a patient with MELAS S Stoquart-ElSankari, P Lehmann, B Périn, C Gondry-Jouet, O Godefroy Journal of neurology 255 (10), 1593, 2008 | 28 | 2008 |
Vincent van PeschCliniques Universitaires Saint-Luc, Université Catholique de Louvain.Подтвержден адрес электронной почты в домене uclouvain.be
